- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有114家主力机构披露2025-06-30报告期持股数据，持仓量总计7357.35万股，占流通A股14.67%
- 波段诊断：
-
技术面诊股
诊断结果：6.0技术面打败了34%的股票
技术面评分前10的股票
近期的平均成本为16.90元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为16.90元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.90","date":1758010243,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.09.17","stock":"-1.58","trade":"-0.79","ind":"1.16"},{"date":"2025.09.16","stock":"-1.50","trade":"1.18","ind":"0.45"},{"date":"2025.09.15","stock":"-0.29","trade":"1.00","ind":"0.63"},{"date":"2025.09.12","stock":"1.40","trade":"1.42","ind":"-0.43"},{"date":"2025.09.11","stock":"0.64","trade":"-0.05","ind":"3.36"},{"date":"2025.09.10","stock":"-1.16","trade":"1.48","ind":"0.38"},{"date":"2025.09.09","stock":"-2.92","trade":"-2.41","ind":"-1.23"},{"date":"2025.09.08","stock":"5.02","trade":"1.77","ind":"0.61"},{"date":"2025.09.05","stock":"2.29","trade":"2.36","ind":"3.89"},{"date":"2025.09.04","stock":"-1.78","trade":"-1.63","ind":"-2.83"},{"date":"2025.09.03","stock":"-2.54","trade":"-0.22","ind":"-0.65"},{"date":"2025.09.02","stock":"-4.26","trade":"-2.00","ind":"-2.14"},{"date":"2025.09.01","stock":"-0.44","trade":"2.46","ind":"1.05"},{"date":"2025.08.29","stock":"3.71","trade":"1.94","ind":"0.99"},{"date":"2025.08.28","stock":"0.06","trade":"-0.23","ind":"2.25"},{"date":"2025.08.27","stock":"5.81","trade":"-2.37","ind":"-1.43"},{"date":"2025.08.26","stock":"-0.60","trade":"-2.26","ind":"0.26"},{"date":"2025.08.25","stock":"0.18","trade":"2.72","ind":"2.26"},{"date":"2025.08.22","stock":"2.41","trade":"0.42","ind":"2.07"},{"date":"2025.08.21","stock":"-1.10","trade":"0.08","ind":"-0.06"},{"date":"2025.08.20","stock":"0.06","trade":"-0.66","ind":"0.89"}]
迪安诊断,深证成指,医疗服务指数
压力支撑
该股压力位为16.95元，支撑位为16.72元。
[{"text":"\u538b\u529b\u4f4d","value":"16.95","date":1758038400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.72","date":1758038400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.8资金面打败了4%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体无进出。
更新时间：09月17日 20:30
| 机构今日流向(万元) | -3273.01 | 机构5日流向(万元) | -1604.43 |
| 机构10日流向(万元) | -8809.80 | 机构20日流向(万元) | -19613.71 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3103.77万股，其中基金净减仓24家，主力净减仓48家，请投资者中长期谨慎为宜。
截止2025-06-30，共114家主力机构（基金110家，一般法人2家，QFII2家），持仓量总计7357.35万股，占流通A股14.67%
其中，基金持仓与2024-12-31相比：
增仓：15家 ，增持 169.69万股
减仓：39家 ，减持 141.13万股
新出现在主力名单中：51家 ，持有3146.56万股
从主力名单中消失：99家 ，原持有4668.44万股
其中，基金持仓与2024-12-31相比：
增仓：15家 ，增持 169.69万股
减仓：39家 ，减持 141.13万股
新出现在主力名单中：51家 ，持有3146.56万股
从主力名单中消失：99家 ，原持有4668.44万股
消息面诊股
诊断结果：5.5消息面打败了29%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 迪安诊断：9月16日获融资买入3711.86万元
2025-09-17 - 迪安诊断“启迪索微算法”成功通过互联网信息服务算法
2025-09-16 - 迪安诊断：9月15日获融资买入3894.26万元
2025-09-16 - 全国肾脏病理与检验前沿论坛在西安召开，迪安诊断补体
2025-09-15 - 迪安诊断：9月12日获融资买入6115.27万元，
2025-09-15 - 行业周报|医疗服务指数涨2.16%, 跑赢上证指数
2025-09-12 - 迪安诊断：9月11日获融资买入5424.46万元，
2025-09-12 - 迪安诊断与邵逸夫医院达成合作，共推肝细胞癌免疫治疗
2025-09-11 - 迪安诊断：9月10日获融资买入5032.14万元
2025-09-11 - 告别“诊断不明、反复试药”困境：迪安诊断癫痫一站式
2025-09-10
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-23 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-23 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-02 |
| 一般消息 | 重大事项 | 关联交易 | 2024-09-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-09-23 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.8行业面打败了82%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.09.17","price":"1.16","value":"-0.79"},{"date":"2025.09.16","price":"0.45","value":"1.18"},{"date":"2025.09.15","price":"0.63","value":"1.00"},{"date":"2025.09.12","price":"-0.43","value":"1.42"},{"date":"2025.09.11","price":"3.36","value":"-0.05"},{"date":"2025.09.10","price":"0.38","value":"1.48"},{"date":"2025.09.09","price":"-1.23","value":"-2.41"},{"date":"2025.09.08","price":"0.61","value":"1.77"},{"date":"2025.09.05","price":"3.89","value":"2.36"},{"date":"2025.09.04","price":"-2.83","value":"-1.63"},{"date":"2025.09.03","price":"-0.65","value":"-0.22"},{"date":"2025.09.02","price":"-2.14","value":"-2.00"},{"date":"2025.09.01","price":"1.05","value":"2.46"},{"date":"2025.08.29","price":"0.99","value":"1.94"},{"date":"2025.08.28","price":"2.25","value":"-0.23"},{"date":"2025.08.27","price":"-1.43","value":"-2.37"},{"date":"2025.08.26","price":"0.26","value":"-2.26"},{"date":"2025.08.25","price":"2.26","value":"2.72"},{"date":"2025.08.22","price":"2.07","value":"0.42"},{"date":"2025.08.21","price":"-0.06","value":"0.08"},{"date":"2025.08.20","price":"0.89","value":"-0.66"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 皓元医药 | 36.77% | 7.54% | 6.8分 |
| 2 | 昭衍新药 | 29.74% | 14.00% | 6.0分 |
| 3 | 普蕊斯 | 29.15% | -1.41% | 6.1分 |
| 4 | 美迪西 | 22.42% | 0.12% | 5.9分 |
| 5 | 毕得医药 | 20.55% | 7.39% | 5.7分 |
| 6 | 博腾股份 | 20.49% | 7.62% | 5.4分 |
| 8 | 康龙化成 | 18.74% | 7.87% | 6.0分 |
| 10 | 成都先导 | 15.10% | 2.27% | 5.5分 |
| 12 | 盈康生命 | 13.87% | -7.84% | 5.6分 |
| 14 | 凯莱英 | 10.70% | 5.15% | 5.6分 |
| 16 | 九洲药业 | 10.01% | 6.47% | 6.7分 |
| 18 | 新里程 | 9.21% | 14.22% | 6.5分 |
| 20 | 皓宸医疗 | 8.59% | 9.69% | 5.6分 |
| 22 | 药康生物 | 6.01% | 0.53% | 7.0分 |
| 24 | 华厦眼科 | 3.29% | 3.24% | 5.8分 |
| 26 | 迪安诊断 | 2.75% | -1.35% | 5.1分 |
| 28 | 睿智医药 | 0.83% | 1.82% | 5.3分 |
| 30 | 通策医疗 | 0.24% | -1.04% | 5.8分 |
| 32 | 和元生物 | -2.23% | 1.41% | 5.8分 |
| 34 | 奥浦迈 | -2.37% | 0.65% | 5.8分 |
| 36 | 爱尔眼科 | -2.72% | 1.02% | 6.0分 |
| 38 | 三博脑科 | -3.34% | 3.56% | 5.5分 |
| 40 | 万邦医药 | -3.71% | 1.63% | 5.1分 |
| 42 | 泓博医药 | -4.80% | 3.12% | 5.7分 |
| 44 | 国际医学 | -6.23% | 0.00% | 5.5分 |
| 46 | 何氏眼科 | -7.80% | 0.93% | 4.6分 |
| 48 | 美年健康 | -10.39% | -0.38% | 5.1分 |
| 50 | 金凯生科 | -11.17% | 0.23% | 4.7分 |
| 52 | 海特生物 | -26.88% | -3.83% | 4.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 37/101 ， 41/101。
[{"date":"2025-06-30","value":"0.16","vol":"2.23"},{"date":"2025-03-31","value":"-0.32","vol":"0.92"},{"date":"2024-12-31","value":"-5.06","vol":"-0.15"},{"date":"2024-09-30","value":"1.79","vol":"3.24"},{"date":"2024-06-30","value":"0.96","vol":"2.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.16 | -0.32 | -5.06 | 1.79 | 0.96 |
| 行业(%) | 2.23 | 0.92 | -0.15 | 3.24 | 2.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"27.59","vol":"36.06"},{"date":"2025-03-31","value":"26.39","vol":"34.67"},{"date":"2024-12-31","value":"28.01","vol":"34.77"},{"date":"2024-09-30","value":"28.05","vol":"36.16"},{"date":"2024-06-30","value":"27.69","vol":"36.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
27.59 | 26.39 | 28.01 | 28.05 | 27.69 |
| 行业(%) | 36.06 | 34.67 | 34.77 | 36.16 | 36.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 46/101 ， 45/101。
[{"date":"2025-06-30","value":"-20.61","vol":"2.42"},{"date":"2025-03-31","value":"-20.45","vol":"-0.08"},{"date":"2024-12-31","value":"-9.04","vol":"-0.73"},{"date":"2024-09-30","value":"-10.05","vol":"0.87"},{"date":"2024-06-30","value":"-9.12","vol":"0.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-20.61 | -20.45 | -9.04 | -10.05 | -9.12 |
| 行业(%) | 2.42 | -0.08 | -0.73 | 0.87 | 0.65 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-85.68","vol":"-71.46"},{"date":"2025-03-31","value":"-190.66","vol":"-25.93"},{"date":"2024-12-31","value":"-216.20","vol":"-96.53"},{"date":"2024-09-30","value":"-75.35","vol":"-161.08"},{"date":"2024-06-30","value":"-84.17","vol":"-107.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-85.68 | -190.66 | -216.20 | -75.35 | -84.17 |
| 行业(%) | -71.46 | -25.93 | -96.53 | -161.08 | -107.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/101 ， 28/101。
[{"date":"2025-06-30","value":"0.32","vol":"0.20"},{"date":"2025-03-31","value":"0.15","vol":"0.10"},{"date":"2024-12-31","value":"0.72","vol":"0.41"},{"date":"2024-09-30","value":"0.53","vol":"0.31"},{"date":"2024-06-30","value":"0.35","vol":"0.20"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.32 | 0.15 | 0.72 | 0.53 | 0.35 |
| 行业(次) | 0.20 | 0.10 | 0.41 | 0.31 | 0.20 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.19","vol":"7.41"},{"date":"2025-03-31","value":"1.07","vol":"3.76"},{"date":"2024-12-31","value":"5.59","vol":"16.35"},{"date":"2024-09-30","value":"4.03","vol":"14.25"},{"date":"2024-06-30","value":"2.89","vol":"8.86"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.19 | 1.07 | 5.59 | 4.03 | 2.89 |
| 行业(次) | 7.41 | 3.76 | 16.35 | 14.25 | 8.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 28/101 ， 18/101。
[{"date":"2025-06-30","value":"17.38","vol":"15.87"},{"date":"2025-03-31","value":"-7.15","vol":"-1.69"},{"date":"2024-12-31","value":"39.25","vol":"22.34"},{"date":"2024-09-30","value":"10.96","vol":"12.23"},{"date":"2024-06-30","value":"-0.37","vol":"9.92"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 17.38 | -7.15 | 39.25 | 10.96 | -0.37 |
| 行业 | 15.87 | -1.69 | 22.34 | 12.23 | 9.92 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.49","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.35","vol":"1.44"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.49 | - | 0.50 | - | 0.35 |
| 行业 | 0.94 | 0.00 | 1.31 | 0.00 | 1.44 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/101 ， 30/101。
[{"date":"2025-06-30","value":"2.68","vol":"3.69"},{"date":"2025-03-31","value":"2.65","vol":"3.84"},{"date":"2024-12-31","value":"2.54","vol":"3.70"},{"date":"2024-09-30","value":"2.61","vol":"4.11"},{"date":"2024-06-30","value":"2.62","vol":"4.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.68 | 2.65 | 2.54 | 2.61 | 2.62 |
| 行业 | 3.69 | 3.84 | 3.70 | 4.11 | 4.14 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.15","vol":"2.98"},{"date":"2025-03-31","value":"2.16","vol":"3.12"},{"date":"2024-12-31","value":"2.08","vol":"3.01"},{"date":"2024-09-30","value":"2.12","vol":"3.38"},{"date":"2024-06-30","value":"2.20","vol":"3.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.15 | 2.16 | 2.08 | 2.12 | 2.20 |
| 行业 | 2.98 | 3.12 | 3.01 | 3.38 | 3.39 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 7/101 ， 10/101。
[{"date":"2025-06-30","value":"43.01","vol":"32.65"},{"date":"2025-03-31","value":"42.54","vol":"32.24"},{"date":"2024-12-31","value":"44.46","vol":"32.31"},{"date":"2024-09-30","value":"44.50","vol":"31.03"},{"date":"2024-06-30","value":"43.96","vol":"31.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
43.01 | 42.54 | 44.46 | 44.50 | 43.96 |
| 行业(%) | 32.65 | 32.24 | 32.31 | 31.03 | 31.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.01","vol":"0.95"},{"date":"2025-03-31","value":"0.99","vol":"0.98"},{"date":"2024-12-31","value":"1.07","vol":"1.01"},{"date":"2024-09-30","value":"1.08","vol":"0.85"},{"date":"2024-06-30","value":"1.04","vol":"0.87"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.01 | 0.99 | 1.07 | 1.08 | 1.04 |
| 行业(%) | 0.95 | 0.98 | 1.01 | 0.85 | 0.87 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东方证券 | 2025-08-27 | 买入 | |
| 中信证券 | 2025-08-26 | 买入 | |
| 中国银河 | 2025-08-22 | 买入 | |
| 中泰证券 | 2025-08-21 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"11.63","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"14.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.57","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.26","blueLineValue":"0.36","type":"YC"}]